Miller Value Partners’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,101,735
Closed -$36.7M 142
2021
Q1
$36.7M Sell
4,101,735
-94,365
-2% -$1.08M 1.04% 41
2020
Q4
$48.4M Sell
4,196,100
-1,078,339
-20% -$12.5M 1.64% 33
2020
Q3
$54.9M Buy
5,274,439
+78,889
+2% +$967K 2.17% 18
2020
Q2
$68.3M Buy
5,195,550
+956,081
+23% +$9.91M 3.03% 8
2020
Q1
$33.4M Sell
4,239,469
-693,406
-14% -$10.4M 2.15% 23
2019
Q4
$102M Sell
4,932,875
-282,935
-5% -$4.77M 3.65% 5
2019
Q3
$71.5M Buy
5,215,810
+363,350
+7% +$4.31M 2.89% 11
2019
Q2
$59.7M Buy
4,852,460
+742,740
+18% +$8.57M 2.38% 22
2019
Q1
$51.3M Buy
4,109,720
+996,330
+32% +$13.3M 2.04% 25
2018
Q4
$35.2M Buy
3,113,390
+232,190
+8% +$3.64M 1.61% 29
2018
Q3
$53.9M Buy
2,881,200
+227,425
+9% +$5.23M 1.76% 28
2018
Q2
$68.6M Sell
2,653,775
-16,125
-0.6% -$418K 2.58% 12
2018
Q1
$59.8M Sell
2,669,900
-14,600
-0.5% -$356K 2.56% 16
2017
Q4
$67.2M Buy
2,684,500
+1,503,175
+127% +$36.8M 2.91% 13
2017
Q3
$28.6M Buy
1,181,325
+653,525
+124% +$15.4M 1.31% 29
2017
Q2
$10.7M Buy
+527,800
New +$11M 0.49% 36

Other funds holding FLXN